Bill Snyder

December 1, 2016

Symposium honors Casagrande’s career

Colleagues of Vivien Casagrande, Ph.D., celebrated her distinguished career in the visual sciences with a “Lifetime of Vision” symposium Nov. 18 in Biological Sciences/Medical Research Building III.

By Bill Snyder
November 28, 2016

Rockefeller University’s Elaine Fuchs, Ph.D., named 2016 recipient of the Vanderbilt Prize in Biomedical Science

Elaine Fuchs, Ph.D., whose innovative use of reverse genetics has helped redefine the study of skin diseases and cancer stem cells, is the recipient of the 2016 Vanderbilt Prize in Biomedical Science, officials at Vanderbilt University Medical Center (VUMC) announced today.

By Bill Snyder
November 25, 2016

Nine Vanderbilt faculty members elected AAAS fellows

Nine Vanderbilt University faculty members have been elected fellows of the American Association for the Advancement of Science this year.

By Bill Snyder
November 21, 2016

Building the basement membrane

Vanderbilt researchers have discovered steps in the regulation of a key enzyme that builds the basement membrane, a structure that undergirds nearly all animal tissues.

By Bill Snyder
November 17, 2016

Graduate student’s cancer studies land NCI support

Kamakoti “Kami” Bhat, a fifth-year graduate student in the lab of David Cortez, Ph.D., professor of Biochemistry in the School of Medicine, has achieved a “first” for Vanderbilt University.

By Bill Snyder
November 7, 2016

Early study finds antibody that ‘neutralizes’ Zika virus

Researchers at Vanderbilt University Medical Center and Washington University School of Medicine in St. Louis have isolated a human monoclonal antibody that in a mouse model “markedly reduced” infection by the Zika virus.

By Bill Snyder
November 3, 2016

Address outlines VUMC’s strategic direction

In his State of the Medical Center address on Wednesday, Jeff Balser, M.D., Ph.D., President and CEO of Vanderbilt University Medical Center (VUMC), and Dean of the Vanderbilt University School of Medicine, described a “Strategic Compass” to help the Medical Center continue to “grow and shine” in the years to come.
By Bill Snyder
November 3, 2016

Brown named interim director of Institute of Chemical Biology

H. Alex Brown, Ph.D., the Bixler-Johnson-Mayes Professor in the Department of Pharmacology, has been named interim director of the Vanderbilt Institute of Chemical Biology (VICB).
By Bill Snyder
October 27, 2016

Vanderbilt’s Dugan, Patel, Wallace set for Discovery Lecture

Three Vanderbilt University neuroscientists on the forefront of research in autism, addiction and Alzheimer’s disease will discuss their cutting-edge investigations during the next Flexner Discovery Lecture on Thursday, Nov. 3.
By Bill Snyder
October 27, 2016

Iadecola set for Oates Lectureship in Clinical Pharmacology

Costantino Iadecola, M.D., an expert in the molecular pathology of ischemic brain injury and neurodegeneration at Weill Cornell Medical College in New York, will present the 10th annual Meredith S. and John A. Oates Lectureship in Clinical Pharmacology on Nov. 3.
By Bill Snyder
October 21, 2016

DNA damage response protein

Vanderbilt researchers have determined that a previously uncharacterized protein responds to DNA replication stress and has an essential role in maintaining the integrity of the genome.
By Bill Snyder
October 20, 2016

Preparing for a return of pox

To prepare for the potential of a smallpox return, Vanderbilt researchers are isolating and studying naturally occurring antibodies from the blood of previously infected or immunized people.
By Bill Snyder
1 … 70 71 72 73 74 … 115